{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:04:58Z","timestamp":1788318298852,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jaci.2022.03.021","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T20:25:27Z","timestamp":1649103927000},"page":"631-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Lirentelimab for severe and chronic forms of allergic conjunctivitis"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-5653","authenticated-orcid":false,"given":"Stephen D.","family":"Anesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg J.","family":"Berdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Terry","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny A.","family":"Asbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford A.","family":"Youngblood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennie H.","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Jhanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik S.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2022.03.021_bib1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/all.12009","article-title":"Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface","volume":"67","author":"Leonardi","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.03.021_bib2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.alit.2016.12.004","article-title":"Japanese guidelines for allergic conjunctival diseases 2017","volume":"66","author":"Takamura","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2022.03.021_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaci.2010.06.050","article-title":"The epidemiology of ocular and nasal allergy in the United States, 1988-1994","volume":"126","author":"Singh","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.03.021_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2332\/allergolint.09-OA-0085","article-title":"Changing prevalence and severity of childhood allergic diseases in Kyoto, Japan, from 1996 to 2006","volume":"58","author":"Kusunoki","year":"2009","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2022.03.021_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1398-9995.1983.tb00852.x","article-title":"Asthma and allergic rhinitis in the same patients","volume":"38","author":"Pedersen","year":"1983","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2022.03.021_bib6","doi-asserted-by":"crossref","first-page":"S773","DOI":"10.1016\/S0091-6749(97)70126-X","article-title":"Overview of comorbid associations of allergic rhinitis","volume":"99","author":"Spector","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.03.021_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anai.2019.11.014","article-title":"ICON: diagnosis and management of allergic conjunctivitis","volume":"124","author":"Bielory","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2022.03.021_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1399-3038.2010.01064.x","article-title":"Disparate geographic prevalences of asthma, allergic rhinoconjunctivitis and atopic eczema among adolescents in five Canadian cities","volume":"21","author":"Wang","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.03.021_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0161-6420(90)32477-6","article-title":"Atopic keratoconjunctivitis","volume":"97","author":"Foster","year":"1990","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2022.03.021_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0161-6420(98)94017-9","article-title":"Long-term follow-up of patients with atopic keratoconjunctivitis","volume":"105","author":"Power","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaci.2022.03.021_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/ACI.0b013e3282ef8674","article-title":"Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities","volume":"7","author":"Leonardi","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.03.021_bib12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00003226-199111000-00011","article-title":"Detection by brush cytology of mast cells and eosinophils in allergic and vernal conjunctivitis","volume":"10","author":"Tsubota","year":"1991","journal-title":"Cornea"},{"key":"10.1016\/j.jaci.2022.03.021_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/iid3.278","article-title":"Role of ocular cytology in vernal keratoconjunctivitis","volume":"8","author":"Bruschi","year":"2020","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaci.2022.03.021_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2222.2006.02499.x","article-title":"Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures","volume":"36","author":"Leonardi","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2022.03.021_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pharmthera.2012.06.005","article-title":"Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions","volume":"135","author":"Kiwamoto","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaci.2022.03.021_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/JLB.2MR0120-352RR","article-title":"Eosinophil and mast cell Siglecs: from biology to drug target","volume":"108","author":"O\u2019Sullivan","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2022.03.021_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/cells10010019","article-title":"Discovery, function, and therapeutic targeting of Siglec-8","volume":"10","author":"Youngblood","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2022.03.021_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126219","article-title":"Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis","volume":"4","author":"Youngblood","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2022.03.021_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000501637","article-title":"AK002, a humanized sialic acid-binding immunoglobulin-like lectin-8 antibody that induces antibody-dependent cell-mediated cytotoxicity against human eosinophils and inhibits mast cell-mediated anaphylaxis in mice","volume":"180","author":"Youngblood","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2022.03.021_bib20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJMoa2012047","article-title":"Anti-siglec-8 antibody for eosinophilic gastritis and duodenitis","volume":"383","author":"Dellon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2022.03.021_bib21","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0002-9394(53)92176-X","article-title":"Atopic keratoconjunctivitis","volume":"36","author":"Hogan","year":"1953","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaci.2022.03.021_bib22","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaci.2022.03.021_bib23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jaci.2010.04.005","article-title":"Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma","volume":"125","author":"Busse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.03.021_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaip.2016.06.022","article-title":"Reactions to rituximab in an outpatient infusion center: a 5-year review","volume":"5","author":"Levin","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2022.03.021_bib25","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/ICL.0000000000000688","article-title":"Potential biomarkers for allergic conjunctival diseases","volume":"46","author":"Roy","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jaci.2022.03.021_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.alit.2020.05.003","article-title":"Ocular allergy test and biomarkers on the ocular surface: clinical test for evaluating the ocular surface condition in allergic conjunctival diseases","volume":"69","author":"Shoji","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2022.03.021_bib27","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/ICO.0000000000002548","article-title":"Roles of type 2 immune response-initiating cytokines and detection of type 2 innate lymphoid cells in mouse models of allergic conjunctivitis","volume":"39","author":"Asada","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.jaci.2022.03.021_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248158","article-title":"Th2 cells and macrophages cooperatively induce allergic inflammation through histamine signaling","volume":"16","author":"Iwasaki","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2022.03.021_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.03.021_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0091-6749(94)90081-7","article-title":"Conjunctivitis medicamentosa","volume":"94","author":"Spector","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2022.03.021_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.ICL.0000092071.82938.46","article-title":"Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis","volume":"30","author":"Ilyas","year":"2004","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jaci.2022.03.021_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2500\/aap.2014.35.3750","article-title":"Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys","volume":"35","author":"Bielory","year":"2014","journal-title":"Allergy Asthma Proc"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922004420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922004420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:37:23Z","timestamp":1758793043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922004420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0091674922004420"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2022.03.021","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lirentelimab for severe and chronic forms of allergic conjunctivitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2022.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}